Effects of aloe vera supplements on blood glucose level and lipid profile markers in type 2 diabetic patients - A randomized clinical trial

Pharmaceutical Sciences

Volumn 21, Issue 2, 2015, Pages 65-71

  Zarrintan, Anita ^a   Mobasseri, Majid ^a   Zarrintan, Armin ^b   Ostadrahimi, Alireza ^c  

^a TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c NONE

Author keywords

Aloe Vera Supplement; Blood Glucose; Diabetes Mellitus; Herbal Medici; Lipid Profile

Indexed keywords

ALOE VERA EXTRACT; CHOLESTEROL; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN; LIPID; LOW DENSITY LIPOPROTEIN; PLACEBO; TRIACYLGLYCEROL;

ALOE VERA; ARTICLE; BLOOD SAMPLING; CHOLESTEROL BLOOD LEVEL; CHRONOTHERAPY; CLINICAL ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; DIABETIC PATIENT; DIET RESTRICTION; DIET SUPPLEMENTATION; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INTERVENTION STUDY; LIPID ANALYSIS; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PARALLEL DESIGN; PREVENTION STUDY; RANDOMIZED CONTROLLED TRIAL; TREATMENT RESPONSE; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 84945348397     PISSN: 1735-403X     EISSN: 2383-2886     Source Type: Journal    
DOI: 10.15171/PS.2015.19     Document Type: Article

References (40)

1. Power AC. Diabetes Mellitus. In: Longo DL, Fauci AS, Kasper DL, Hauser SL, Jamson JL, Loscalzo J : Harrison's Principles Of Internal Medicine. McGrow-Hill, Columbus, 2012:2968-2975.
2. Lynn Maori, Dorcas Ezekiel and Joy Bilal. Prevalence of Diabetes in Zambuk General Hospital. Rep Opinion 2012;4:54-57.
3. Williams Textbook of Endocrinology 12th ed: Elsevier/Saunders. Philadelphia pp. 1371-1435.
4. "International Diabetes Federation: Diabetes Atlas" www.idf.org/diabetesatlas. Retrieved 4 April 2014.
5. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes care 2004;27:1047-53. doi:10.2337/diacare.27.10.2569-a
6. Hajianfar H, Bahonar A, Entezari MH, Askari G, Yazdani M. Lipid Profiles and Serum Visfatin Concentrations in Patients with Type II Diabetes in Comparison with Healthy Controls. Int J Prev Med 2012;3:326-331.
7. Singla R, Ambekar S, Nand K, Singh MB, Gupta N, Jyotsna VP. Profile of type 2 diabetes mellitus without overt complications of diabetes mellitus at a tertiary care center. Indian J Endocrinol Metab 2012;16:S468-470. doi: 10.4103/2230-8210.104134.
8. Yong QW, Thavintharan S, Cheng A, Chew LS. The effect of fenofibrate on insulin sensitivity and plasma lipid profile in non-diabetic males with low high density lipoprotein/dyslipidaemic syndrome. Ann Acad Med Singapore 1999;28:778-782.
9. Rivellese AA, Patti L, Romano G, Innelli F, Di Marino L, Annuzzi G, et al. Effect of insulin and sulfonylurea therapy, at the same level of blood glucose control, on low density lipoprotein subfractions in type 2 diabetic patients. J Clin Endocrinol Metab 2000;85:4188-4192. doi: 10.1210/jc.85.11.4188
10. Breslavsky A, Frand J, Matas Z, Boaz M, Barnea Z, Shargorodsky M. Effect of high doses of vitamin D on arterial properties, adiponectin, leptin and glucose homeostasis in type 2 diabetic patients. Clin Nutr 2013;32:970-975. doi: 10.1016/j.clnu.2013.01.020
11. Lee HJ, Kang MH. Effect of the magnetized water supplementation on blood glucose, lymphocyte DNA damage, antioxidant status, and lipid profiles in STZ-induced rats. Nutr Res Pract 2013;7:34-42. doi: 10.4162/nrp.2013.7.1.34
12. Jha P, Das BK, Shrestha S, Majhi S, Chandra L, Sharma S, et al. Glycemic status, lipid profile and proteinuria in diabetic nephropathy. J Nepal Med Assoc 2010;49:143-146.
13. Al Faris NA, Al Othman ZA, Ahmad D. Effects of Mesembrrybryanthemum forsskalei Hochst seeds in lowering glucose/lipid profile in streptozotocin-induced diabetic rats. J Food Sci Technol 2011; 48: 616-621.
14. Yeh GY, Eisenberg DM, Kaptchuk TJ, Phillips RS. Systematic review of herbs and dietary supplements for glycemic control in diabetes. Diabetes Care 2003;26:1277-1294. doi: 10.2337/diacare.26.4.1277.
15. Lee T, Dugoua JJ. Nutritional supplements and their effect on glucose control. Curr Diabetes Rep 2011;11:142-148. doi: 10.1007/978-1-4614-5441-0-27
16. Foster M, Hunter D, Samman S. Evaluation of the Nutritional and Metabolic Effects of Aloe vera. In: Benzie IFF, Wachtel-Galor S, editors. Herbal Medicine: Biomolecular and Clinical Aspects. 2nd ed. Boca Raton FL;2011.
17. Heber D. Physicians' Desk Reference for Herbal Medicines. 4th. Montvale, NJ: Thomson;2007.
18. Lans C.A. Ethnomedicines used in Trinidad and Tobago for urinary problems and diabetes mellitus. J Ethnobiol Ethnomed 2006;2:45-55.
19. Coronado G.D, Thompson B, Tejeda S, Godina R. Attitudes and beliefs among Mexican Americans about type 2 diabetes. J Health Care Poor Underserved 2004;15:576-588. doi:10.1353/hpu.2004.0057
20. Perez YY, Jimenez-Ferrer E, Zamilpa A, Hernandez-Valencia M, Alarcon-Aguilar FJ, Tortoriello J, et al. Effect of a polyphenol-rich extract from Aloe vera gel on experimentally induced insulin resistance in mice. Am J Chin Med 2007;35:1037-1046. doi: 10.1142/S0192415X07005491
21. Okyar A, Can A, Akev N, Baktir G, Sutlupinar N. Effect of Aloe vera leaves on blood glucose level in type I and type II diabetic rat models. Phytother Res 2001;15:157-161. doi: 10.1002/ptr.719
22. Shin S, Kim S, Oh HE, Kong H, Shin E, Do SG, et al. Dietary Aloe QDM Complex Reduces Obesity-Induced Insulin Resistance and Adipogenesis in Obese Mice Fed a High-Fat Diet. Immune Netw 2012;12:96-103. doi:10.4110/in.2012.12.3.96
23. Gundidza M, Masuku S, Humphrey G, Magwa ML. Anti-diabetic activity of Aloe excelsa. Cent Afr J Med. 2005;51:115-120.
24. Devaraj S, Yimam M, Brownell LA, Jialal I, Singh S, Jia Q. Effects of Aloe vera supplementation in subjects with prediabetes/metabolic syndrome. Metab Syndr Relat Disord. 2013;11:35-40. doi:10.1089/met.2012.0066
25. Tanaka M, Misawa E, Ito Y, Habara N, Nomaguchi K, Yamada M, et al. Identification of five phytosterols from Aloe vera gel as anti-diabetic compounds. Biol Pharm Bull 2006;29:1418-1422. doi: 10.1248/bpb.29.1418
26. Kim K, Kim H, Kwon J, Lee S, Kong H, Im SA, et al. Hypoglycemic and hypolipidemic effects of processed Aloe vera gel in a mouse model of non-insulin-dependent diabetes mellitus. Phytomedicine: Int J Phytother Phytopharm 2009;16:856-863. doi: 10.1016/j.phymed.2009.02.014
27. Davis RH, Maro NP. Aloe vera and gibberellin. Anti-inflammatory activity in diabetes. J Am Podiatr Med Assoc 1989;79:24-26. doi: 10.7547/87507315-79-1-24
28. Laitiff AA, Teoh SL, Das S. Wound healing in diabetes mellitus: traditional treatment modalities. La Clinica Ter 2010;161:359-364.
29. Inpanya P, Faikrua A, Ounaroon A, Sittichokechaiwut A, Viyoch J. Effects of the blended fibroin/aloe gel film on wound healing in streptozotocin-induced diabetic rats. Biomed Mater 2012;7:035008. doi: 10.1088/1748-6041/7/3/035008
30. Jain N, Vijayaraghavan R, Pant SC, Lomash V, Ali M. Aloe vera gel alleviates cardiotoxicity in streptozocin-induced diabetes in rats. J Pharm Pharmacol. 2010;62:115-123. doi: 10.1211/jpp.62.01.0013
31. Bolkent S, Akev N, Ozsoy N, Sengezer-Inceli M, Can A, Alper O, et al. Effect of Aloe vera (L.) Burm. fil. leaf gel and pulp extracts on kidney in type-II diabetic rat models. Indian J Exp Biol 2004;42:48-52.
32. Can A, Akev N, Ozsoy N, Bolkent S, Arda BP, Yanardag R, et al. Effect of Aloe vera leaf gel and pulp extracts on the liver in type-II diabetic rat models. Biol Pharm Bull 2004;27:694-698. doi: 10.1248/bpb.27.694
33. Uddin F, Miah AK. Lipid profile and its relation to fasting insulin level in non-insulin dependent diabetes mellitus (NIDDM). Bangladesh Med Res Counc Bull 1995;21:64-72.
34. Abdel-Gayoum AG. The effect of glycemic control in type 2 diabetic patients with diabetes-related dyslipidemia. Saudi Med J 2004;25:207-211.
35. Elnasri HA, Ahmed AM. Patterns of lipid changes among type 2 diabetes patients in Sudan. East Mediterr Health J 2008;14:314-324.
36. Emerging Risk Factors C, Sarwar N, Gao P, Seshasai SR, Gobin R, Kaptoge S, et al. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet 2010;375:2215-2222. doi: 10.1016/S0140-6736(10)60484-9
37. Rajasekaran S, Ravi K, Sivagnanam K, Subramanian S. Beneficial effects of aloe vera leaf gel extract on lipid profile status in rats with streptozotocin diabetes. Clin Exp Pharmacol Physiol 2006;33:232-237. doi:10.1111/j.1440-1681.2006.04351.x
38. Bunyapraphatsara N, Yongchaiyudha S, Rungpitarangsi V, Chokechaijaroenporn O. Antidiabetic activity of Aloe vera L. juice II. Clinical trial in diabetes mellitus patients in combination with glibenclamide. Phytomedicine 1996;3:245-248. doi: 10.1016/S0944-7113(96)80061-4.
39. Huseini HF, Kianbakht S, Hajiaghaee R, Dabaghian FH. Anti-hyperglycemic and anti-hypercholesterolemic effects of Aloe vera leaf gel in hyperlipidemic type 2 diabetic patients: a randomized double-blind placebo-controlled clinical trial. Planta Med 2012;78:311-316. doi: 10.1055/s-0031-1280474
40. Vogler BK, Ernst E. Aloe vera: a systematic review of its clinical effectiveness. Br J Gen Pract 1999;49:823-828.